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Abstract:
This series of studies addresses several conceptual issues in modern pain therapy related to the 
contemporary  understanding of mechanisms and modulators involved in the pain sensation. Novel 
invasive therapy for severe pain, neurogenic interactions, humoral regulators and cellular responses 
were studied. 
Methods: I) Continuous intrathecal (IT) bupivacaine administration at  intracisternal or high cervical 
levels in patients with severe refractory pain, II) Isotope-dilution techniques for analysis of 
baroreflex responses and catecholamine release in this patient group, III) Differential analysis of 
activities of cytokines, including glial cell line-derived neurotrophic factor (GDNF), in intrathecal 
and blood compartments in patients with long-term pain due to osteoarthritis, and IV) Co-
cultivation of astrocytes for imaging and quantification of changes in Ca2+ signalling when 
activated by pro-inflammatory lipopolysaccharide (LPS) and interleukin-1β (IL-1β).
Results and conclusions: I) For patients with severe pain in areas innervated by cranial and upper 
cervical nerves not responding to conventional pharmacological pain therapy, cervical high spinal 
analgesia is a valuable and safe option with clinical good results, II) Acute administration of 
intracisternal bupivacaine is associated with increases in systemic blood pressure and heart rate as a 
result of substantial augmentation of efferent reflex sympathetic nervous activity. We propose this 
reflects a bupivacaine-induced reduction of afferent baroreceptor discharge to the brain stem, III) 
Long-term pain is associated with increased levels of GDNF in cerebrospinal fluid (CSF), but 
decreased levels in blood and simultaneously increased levels of pro-inflammatory cytokines in 
CSF and blood, and IV) LPS and the cytokine IL-1β attenuate GDNF-induced Ca2+-signalling in 
co-cultured astrocytes, and induce conformational changes of the cytoskeleton. Naloxone and 
ifenprodil restore LPS-attenuated Ca2+-transients, and naloxone also restores the conformational 
changes of the cytoskeleton.
Key words: Head and neck, pain, cisterna magna, baroreflex, noradrenaline, GDNF, osteoarthritis, 
co-cultured astrocytes, naloxone, calcium
ISBN 978-91-628-7885-6
